Your cookies are not enabled, you will not be able to use any of PhysiciansOfficeResource.com advanced features.
To learn how to enable your cookies, please visit our How To Enable Cookies page
CURRENT SPONSORS




RELATED NEWS
Addrenex Pharmaceuticals Announces Positive Phase III Clinical Results for Clonicel to Treat ADHD
Read Full Article »
Chemokine Protein CXCR3 Receptor Found in Celiac Disease
Read Full Article »
Incentives to e-Prescribe
Read Full Article »
Silent Stroke Affects 10 Percent of Healthy Middle-Aged Patients
Read Full Article »
Vitamin D Deficiency Associated with Increased Risk of Heart Disease
Read Full Article »
ESA CLIA Waived Blood Lead Testing

Anticholinergic Drugs May Increase Cognitive Decline in Older People

Anticholinergic drugs, such as medicines for stomach cramps, ulcers, motion sickness, and urinary incontinence, may cause older people to experience greater decline in their thinking skills than people not taking the drugs, according to research that will be presented at the American Academy of Neurology 60th Anniversary Annual Meeting in Chicago, April 12–19, 2008.

The study looked at the effects of taking a medication with anticholinergic properties on the annual change in thinking abilities of 870 Catholic nuns and clergy members who were an average of 75 years old.

All of the participants were part of the Rush Religious Orders Study, an ongoing, longitudinal, clinical study of older people without dementia. All of the participants underwent annual cognitive tests and reported their medication use for an average followup period of eight years. During the study, 679 people took at least one medication with anticholinergic properties.

The study found those people who took anticholinergic drugs saw their rate of cognitive function decline 1.5 times as fast as those people who did not take the drugs.

“Our findings point to anticholinergic drugs having an adverse impact on cognitive performance in otherwise normal, older people,” said study author Jack Tsao, MD, DPhil, Associate Professor of Neurology at Uniformed Services University in Bethesda, Maryland, and member of the American Academy of Neurology.

“Doctors may need to take this into account before prescribing these commonly used drugs.” Tsao says more research is needed to determine the mechanism behind the rapid memory loss apparently associated with anticholinergic drugs and to identify which drugs, in particular, may be more likely to impair cognition.


Source: Report Delivered at the American Academy of Neurology 60th Anniversary Annual Meeting, April 12-19, 2008